NCT05604235Completed
Effectiveness of Oncological Physiotherapy on Painful Shoulder Cervical Ganglion in Head and Neck Cancer
Effectiveness of Oncological Physiotherapy With Neurodynamics and Kinesitherapy (Active+Passive) on Painful Shoulder Cervical Ganglion Post Cervical Evacuation in Head and Neck Cancer Due to Accessory Spinal Nerve of the Accessory Spinal Nerve
Source: ClinicalTrials.gov · Last updated 20 Nov 2024
Brief summary (registry, in English)
Objective: To estimate whether oncological physiotherapy treatment with neurodynamic and kinesitherapy (passive and active) in patients with "painful shoulder due to accessory spinal nerve dissection" operated on for head and neck cancer is more effective than standard therapeutic exercise therapy with strength. Design: Randomized Clinical Trial (intervention study, no drugs). Two branches of rehabilitative treatment applied by oncological physiotherapist. GROUP I: Treatment of passive and active mobilizations together with neurodynamics techniques. GROUP II (or control group) Current treatment applied as gold standard, consisting of therapeutic strength exercise, which the patient will carry out under the supervision of the physiotherapist. The frequency of both will be twice a week for two months. Study subjects: Participants who underwent cervical ganglion dissection surgery for head and neck cancer, and who have, as a surgical sequela, a painful shoulder due to accessory spinal nerve injury. Determinations: At baseline (t0), at one month (t1m) and at the end (t6m) will be measured, (1) the degree of pain of the participants through the pain scale (EVA), (2) the functionality of the shoulder, with the DASH scale and goniometry, (3) the quality of life with the QLQ H\&N35 questionnaire, (4) the strength with a hand dynamometer and (5) the degree of neurodynamics of the accessory spinal nerve with the neurodynamic test for this nerve.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 27 Oct 2022
- Start date
- 15 Nov 2022
- Primary completion date
- 15 Jun 2024
- Lead sponsor
- University of Alcala
- Diseases
- Head and neck cancer
- NCT number
- NCT05604235
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 15 Nov 2022 to the primary completion date, 15 Jun 2024
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with functional limitations in the shoulder prior to surgery or that can be demonstrated to be due to other causes.
Other
- Patients with bone metastases
- Patients who are minors
- Incident cases of painful shoulder in patients with
- Cervical level I lymph node dissection
Who the study is looking for
- Patients with cancer located in the head and neck.
- Different types of cancer, undergoing cervical lymph node dissection between levels II and V, with pain and/or functional impotence in the shoulder.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Physiotherapy and Pain Institute Coordinator of this site? Confirm its status | Alcalá de Henares | Spain | Unknown status |
| Centro Investigación Fisioterapia y Dolor Coordinator of this site? Confirm its status | Alcalá de Henares | Spain | Unknown status |
| Patricia Martinez Merinero Coordinator of this site? Confirm its status | Alcalá de Henares | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.